146 related articles for article (PubMed ID: 23438034)
1. Surface functionality as a means to impact polymer nanoparticle size and structure.
Schneider J; Jallouk AP; Vasquez D; Thomann R; Forget A; Pino CJ; Shastri VP
Langmuir; 2013 Mar; 29(12):4092-5. PubMed ID: 23438034
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle diffusion within intestinal mucus: Three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles.
Abdulkarim M; Agulló N; Cattoz B; Griffiths P; Bernkop-Schnürch A; Borros SG; Gumbleton M
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):230-8. PubMed ID: 25661585
[TBL] [Abstract][Full Text] [Related]
3. Single-step process to produce surface-functionalized polymeric nanoparticles.
Sussman EM; Clarke MB; Shastri VP
Langmuir; 2007 Nov; 23(24):12275-9. PubMed ID: 17963413
[TBL] [Abstract][Full Text] [Related]
4. In Situ Characterization of Binary Mixed Polymer Brush-Grafted Silica Nanoparticles in Aqueous and Organic Solvents by Cryo-Electron Tomography.
Fox TL; Tang S; Horton JM; Holdaway HA; Zhao B; Zhu L; Stewart PL
Langmuir; 2015 Aug; 31(31):8680-8. PubMed ID: 26174179
[TBL] [Abstract][Full Text] [Related]
5. Controlled association and delivery of nanoparticles from jet-sprayed hybrid microfibrillar matrices.
Keloglu N; Verrier B; Trimaille T; Sohier J
Colloids Surf B Biointerfaces; 2016 Apr; 140():142-149. PubMed ID: 26752211
[TBL] [Abstract][Full Text] [Related]
6. Tuning the Size of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles Fabricated by Nanoprecipitation.
Huang W; Zhang C
Biotechnol J; 2018 Jan; 13(1):. PubMed ID: 28941234
[TBL] [Abstract][Full Text] [Related]
7. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
Budhian A; Siegel SJ; Winey KI
Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
9. Impact of bulk and surface properties of some biocompatible hydrophobic polymers on the stability of methylene chloride-in-water mini-emulsions used to prepare nanoparticles by emulsification-solvent evaporation.
Babak VG; Baros F; Boulanouar O; Boury F; Fromm M; Kildeeva NR; Ubrich N; Maincent P
Colloids Surf B Biointerfaces; 2007 Oct; 59(2):194-207. PubMed ID: 17600692
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):214-20. PubMed ID: 21439797
[TBL] [Abstract][Full Text] [Related]
11. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
Cheng J; Teply BA; Sherifi I; Sung J; Luther G; Gu FX; Levy-Nissenbaum E; Radovic-Moreno AF; Langer R; Farokhzad OC
Biomaterials; 2007 Feb; 28(5):869-76. PubMed ID: 17055572
[TBL] [Abstract][Full Text] [Related]
12. Polyethylene glycol as an alternative polymer solvent for nanoparticle preparation.
Ali ME; Lamprecht A
Int J Pharm; 2013 Nov; 456(1):135-42. PubMed ID: 23958752
[TBL] [Abstract][Full Text] [Related]
13. The influence of technological parameters on the physicochemical properties of blank PLGA nanoparticles.
Ozturk K; Caban S; Kozlu S; Kadayifci E; Yerlikaya F; Capan Y
Pharmazie; 2010 Sep; 65(9):665-9. PubMed ID: 21038843
[TBL] [Abstract][Full Text] [Related]
14. Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approach.
Rose F; Wern JE; Ingvarsson PT; van de Weert M; Andersen P; Follmann F; Foged C
J Control Release; 2015 Jul; 210():48-57. PubMed ID: 25957906
[TBL] [Abstract][Full Text] [Related]
15. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
16. Poly(lactic-co-glycolic acid) as a particulate emulsifier.
Whitby CP; Lim LH; Eskandar NG; Simovic S; Prestidge CA
J Colloid Interface Sci; 2012 Jun; 375(1):142-7. PubMed ID: 22440727
[TBL] [Abstract][Full Text] [Related]
17. Novel one-pot facile technique for preparing nanoparticles modified with hydrophilic polymers on the surface via block polymer-assisted emulsification/evaporation process.
Kanakubo Y; Ito F; Murakami Y
Colloids Surf B Biointerfaces; 2010 Jun; 78(1):85-91. PubMed ID: 20223642
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
[TBL] [Abstract][Full Text] [Related]
19. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
[TBL] [Abstract][Full Text] [Related]
20. Monodisperse PLA/PLGA nanoparticle fabrication through a surfactant-free route.
Liang R; Zhu J
J Control Release; 2011 Nov; 152 Suppl 1():e129-31. PubMed ID: 22195799
[No Abstract] [Full Text] [Related]
[Next] [New Search]
